TruNorth Platform™
Behavioral Healthcare for the 21st Century
When it comes to healthcare, whether for our bodies or our minds, we trust in science & compassion to guide us, like a compass, along the best path forward.
Today’s subjective diagnostics & outdated treatments for behavioral health conditions take into account a very limited amount of subjective information about us. The problem is that we are each more than a one-size-fits-all diagnosis or treatment plan. Behavioral health is complex & informed by many factors, including our genetics & other aspects of our physical health.
Ignoring all of the factors that make up the whole picture of our health only leaves room for more suffering & stigma.
The Polaris TruNorth Platform™ is a secure, cloud-based bioinformatic data analysis engine that helps clinicians see a person’s health through this whole-picture viewpoint. Using machine learning & artificial intelligence algorithms, the TruNorth Platform™ rapidly & accurately analyzes PTS-ID™ & other multi-omic data.
By integrating data from many evidence-based tools, the TruNorth Platform™ delivers effective, actionable, & objective reports for therapeutic decision support, from risk identification to treatment optimization.
The Proof of PTSD Lies in the Science, Not the Subjective
Current subjective PTSD assessments put the burden on people to “prove” they suffer from PTSD, leaving many to fall through the cracks.
The TruNorth Platform™ puts the onus on science — where it should be — & leads us to the answers that are found only in our DNA.
- Step 1: Embark. At the onset, a person provides a blood sample & completes a behavioral risk survey.
- Step 2: Pinpoint Risk. The blood sample is processed through our PTS-ID™ assay & any dysregulation is determined through examination of three PTSD biomarkers.
- Step 3: Broad-Scope Bioinformatics. Genomic analysis, a survey, & additional data are integrated & assessed to identify the person’s PTSD risk.
- Step 4: Whole-Patient Perspective. Creation of the person’s PTSD risk profile & report informs the clinician’s therapeutic decisions.